[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect]

Nihon Shokakibyo Gakkai Zasshi. 1988 Nov;85(11):2411-9.
[Article in Japanese]
No abstract available

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Ascites / chemically induced
  • Brain Diseases / chemically induced
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Neoplasms / complications
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Risk Factors
  • Tegafur / adverse effects*
  • Tegafur / blood
  • Time Factors
  • Uracil / adverse effects

Substances

  • Tegafur
  • Uracil

Supplementary concepts

  • 1-UFT protocol